The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer

Citations Over TimeTop 10% of 1994 papers

Abstract

CEA was the first indicator of recurrent disease in 58 percent of all patients and in 80 percent of patients with liver metastases. The diagnosis of recurrent disease may be made several months earlier by investigating the first abnormal CEA level, although any benefit in terms of survival remains to be proven.

Related Papers

• → High preoperative serum carcinoembryonic antigen predicts metastatic recurrence in potentially curative colonic cancer(2001)89 cited
• Elevated carcinoembryonic antigen (CEA) levels in a patient with no malignancy.(2000)
• The use of serial carcinoembryonic antigen determinations to predict recurrence of carcinoma of the colon and the time for a second-look operation.(1978)
• [Carcinoembryonic antigen in diagnosis and monitoring of colorectal cancer].(1998)
• Relationship of intestinal obstruction to serial plasma carcinoembryonic antigen levels.(1980)